Emil Kendziorra
Doctor. Entrepreneur. Revolutionized Medicine. Chairman Of The Board at EBF
Emil Kendziorra, M.D. is Founder of onfeedback GmbH and CEO of BerlinStartupmap.
Emil launches startups in Berlin. They are mainly in ecommerce and ehealth.
Emil earned his M.D. at the University of Göttingen, Medical School, Germany in 2012.
Visit website: https://lifeboat.com/ex/bios.emil.kendziorra
See also: 
EBF - European Biostasis Foundation
- Dedicated to research in the areas of biostasis, cryobiology and biopreservation
Details last updated 18-Jun-2020
Emil Kendziorra is also referenced in the following:
Alcor Conference 2022
03-Jun-2022 to 05-Jun-2022
Conference about cryonics and life extension organized by Alcor with David Chalmers and George Church as featured speakers
Biostasis Symposium UK
20-May-2023
A chance for UK cryonicists to mingle and hear from important figures in the cryonics field, organized by Tomorrow Bio (FREE)
Cryonics webinar
12-Feb-2023
Max More, Emil Kendziorra, Peter Tsolakides speak at this Madrid Singularity hosted by Jose Cordeiro
Longevity Investors Conference 2023
27-Sep-2023 to 29-Sep-2023
Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger, Dr. Tobias Reichmuth and Daniel Koetser
Tomorrow Bio
Founded by doctors, engineers, and entrepreneurs to further biostasis science and provide a high quality cryopreservation
Emil Kendziorra News
Emil Kendziorra explains how Tomorrow Biostasis will cryopreserve your body
Sifted - 02-Feb-2021
Good to have another cyronics provider in Europe
Read more...Leading longevity researchers to speak at global investment conference
Longevity Technology - 17-Jun-2020
Most people (including me!) won't have enough money to attend, but it's good to see more interest in longevity investments
Read more...Articles written by Emil Kendziorra
Emil Kendziorra explains why he set up the European Biostasis Foundation
Medium - 21-May-2020
I'm not sure survivable cryonics is an easier problem than ageing, but good to have a plan B
Read more...
